Autoschizis

Autoschizis is a form of cell death that is characterized by the loss of cytoplasmic content through self-excision. This process is distinct from other forms of cell death such as apoptosis and necrosis in that it does not involve the breakdown of the cell's nuclear material. Instead, the cell's cytoplasmic content is lost through a process of self-excision, leading to the formation of a residual body that is eventually phagocytosed by neighboring cells.

Mechanism

The exact mechanism of autoschizis is not fully understood. However, it is believed to involve a series of steps that lead to the loss of cytoplasmic content. First, the cell undergoes a process of self-excision, in which parts of the cytoplasm are cut away. This is followed by the formation of a residual body, which is a small, dense structure that remains after the loss of cytoplasmic content. Finally, the residual body is phagocytosed by neighboring cells, effectively removing the cell from the tissue.

Role in Disease

Autoschizis has been observed in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. In cancer, autoschizis may play a role in the death of tumor cells, potentially contributing to the effectiveness of certain chemotherapy drugs. In neurodegenerative diseases, autoschizis may contribute to the loss of neurons, leading to the symptoms of these diseases. In autoimmune diseases, autoschizis may play a role in the death of immune cells, potentially contributing to the progression of these diseases.

Research

Research into autoschizis is ongoing, with scientists seeking to better understand the mechanism of this form of cell death and its role in disease. This research could potentially lead to new treatments for diseases in which autoschizis plays a role.

See Also

• Cell death
• Apoptosis
• Necrosis
• Cancer
• Neurodegenerative diseases
• Autoimmune diseases

Autoschizis Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.